BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Drug Development

  Teva Pharmaceutical Industries Limited to Present Further Results of Twenty-Year Open-Label Extension Study of Glatiramer Acetate 20 mg Daily for Relapsing-Remitting Multiple Sclerosis

  October 3, 2013

   · 

  8 min read
• FDA

  Valeant Pharmaceuticals International Announces Approval of Jublia® for the Treatment of Onychomycosis in Canada

  October 3, 2013

   · 

  4 min read
• Job Trends

  Synergetics USA, Inc. Consolidates Operations, Cuts Jobs

  October 3, 2013

   · 

  1 min read
• Drug Development

  Delcath Systems, Inc. Finally Gets Good News From the FDA

  October 3, 2013

   · 

  1 min read
• Policy

  Arthrex, Inc. Ordered to Stop Selling Infringing Products

  October 3, 2013

   · 

  3 min read
• Business

  EXINI Signs New Commercial Agreement With Pharmaceutical Company

  October 3, 2013

   · 

  1 min read
• Drug Development

  Biogen Idec, Inc. (Massachusetts) Release: New TYSABRI® Data Show Earlier Treatment and Longer-Term Use Result in Significant Reductions in MS Disease Activity

  October 3, 2013

   · 

  1 min read
• Business

  NJ’s Pain is NY’s Gain as Roche Unveils Manhattan Research Hub

  October 3, 2013

   · 

  1 min read
• BioMidwest

  Eli Lilly and Company Says It Must Cut Costs to Meet 2014 Goals

  October 3, 2013

   · 

  11 min read
• Job Trends

  Pharmaceutical Startup, KenCord Bio Therapeutics Promises 200 New Jobs

  October 3, 2013

   · 

  1 min read